Tisza Party Emerges as Leading Opposition Force in Hungary

  • 15 May 2024 7:18 AM
  • Hungary Around the Clock
Tisza Party Emerges as Leading Opposition Force in Hungary
The Tisza Party is supported by 26% of decided voters, behind Fidesz at 39%, and ahead of the alliance of the Democratic Coalition, Socialist and Dialogue parties, according to the latest survey by Závecz Research, commissioned by RTL.

Other parties are hovering around the 5% threshold for entry into the European Parliament, with support levels of 6% for Our Homeland, 4% for Momentum, and 3% for the Two-Tailed Dog Party.

According to calculations by news website 24 and the Political Capital think tank, this will translate into ten MEP seats for Fidesz, six for the Tisza Party, four for the centre-left alliance, and one for Our Homeland.

Among all eligible voters, 28% favour Fidesz, about 2.2 million people, 19%, or 1.5 million prefer the Tisza party, and 12% support the centre-left alliance, about 1 million people.

Another 24% of respondents did not express a preference.

The results are based on a representative survey of 1,000 Hungarian citizens aged 18 and above during May 2 -10.

*********************************

You're very welcome to comment, discuss and enjoy more stories, via our Facebook page: 
Facebook.com/XpatLoopNews + via XpatLoop’s groups: Budapest Expats / Expats Hungary

You can subscribe to our newsletter here:
XpatLoop.com/Newsletters

Do you want your business to reach tens of thousands of potential high-value expat customers?
Then just contact us here!

Related links

Photos: Unprecedented Crowds at Péter Magyar's Latest Rally in Hungary

  • How does this content make you feel?

XpatLoop Media Partner

Hungary Around the Clock

Since 1995 Hungary Around the Clock has proven to be one of the most comprehensive sources of daily English-language news about Hungary. It covers ongoing domestic politics and foreign relations, as well as business and economic matters. For a free trial of HATC visit www.hatc.hu and click on 'Free Trial Subscription’.

Explore More Reports